تحميل...

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

OBJECTIVE: To evaluate the relationship between number of metabolic syndrome (MetS)-like components and prostate cancer diagnosis in a group of men where nearly all biopsies were taken independent of prostate-specific antigen (PSA) level, thus minimising any confounding from how the various MetS-lik...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	BJU Int
المؤلفون الرئيسيون:	Sourbeer, Katharine N., Howard, Lauren E., Andriole, Gerald L., Moreira, Daniel M., Castro-Santamaria, Ramiro, Freedland, Stephen J., Vidal, Adriana C.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	2014
الموضوعات:	Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4564864/ https://ncbi.nlm.nih.gov/pubmed/24931061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.12843
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

مواد مشابهة